 |
| 동국제약 본사 전경 (사진=동국제약) |
[Alpha Biz= Reporter Kim Jisun] Dongkook Pharmaceutical has announced its acquisition of 96,600 shares of reBom Cosmetics for 30.7 billion won, as disclosed on October 15. This move aims to secure new growth engines and diversify its business.
Founded in 2010, reBom Cosmetics specializes in ODM (Original Design Manufacturing) in the cosmetics sector.
With this stock acquisition, Dongkook Pharmaceutical will become the largest shareholder, holding a 53.66% stake. The acquisition is expected to be completed on October 22.
Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)
